Froedtert Holy Family Memorial Reed Avenue

Froedtert Holy Family Memorial Reed Avenue, based in Philadelphia, PA, is one of the SAMHSA-registered treatment programs operating in PA. The specific care levels offered by Froedtert Holy Family Memorial Reed Avenue should be confirmed directly with the admissions team. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Froedtert Holy Family Memorial Reed Avenue

The care-level question matters because what a facility offers is what it can realistically treat well. Care-level specifics for Froedtert Holy Family Memorial Reed Avenue are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Froedtert Holy Family Memorial Reed Avenue's offerings match the clinical need.

Insurance and payment

On insurance specifically: Payment and insurance specifics for Froedtert Holy Family Memorial Reed Avenue are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Froedtert Holy Family Memorial Reed Avenue offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Programs that cannot answer all three quickly are programs worth approaching with caution.